Klaushofer K - Search Results

1

Incidence and costs of osteoporosis-associated hip fractures in Austria.

Koeck CM, Schwappach DL, Niemann FM, Strassmann TJ, Ebner H, Klaushofer K. Koeck CM, et al. Among authors: klaushofer k. Wien Klin Wochenschr. 2001 May 15;113(10):371-7. Wien Klin Wochenschr. 2001. PMID: 11432126

2

Mortality after hip fracture in Austria 2008-2011.

Brozek W, Reichardt B, Kimberger O, Zwerina J, Dimai HP, Kritsch D, Klaushofer K, Zwettler E. Brozek W, et al. Among authors: klaushofer k. Calcif Tissue Int. 2014 Sep;95(3):257-66. doi: 10.1007/s00223-014-9889-9. Epub 2014 Jul 3. Calcif Tissue Int. 2014. PMID: 24989776

3

[Guidelines for drug therapy of postmenopausal osteoporosis].

Dimai HP, Pietschmann P, Resch H, Leb G, Klaushofer K. Dimai HP, et al. Among authors: klaushofer k. Wien Med Wochenschr. 2002;152(23-24):596-612. doi: 10.1046/j.1563-258x.2002.d01-16.x. Wien Med Wochenschr. 2002. PMID: 12530170 Review. German.

4

[Austrian guidance for the pharmacologic treatment of osteoporosis in postmenopausal women: Addendum 2010].

Dimai HP, Pietschmann P, Resch H, Preisinger E, Fahrleitner-Pammer A, Dobnig H, Klaushofer K; Austrian Society for Bone and Mineral Research (AuSBMR). Dimai HP, et al. Among authors: klaushofer k. Wien Med Wochenschr. 2010 Dec;160(21-22):586-9. doi: 10.1007/s10354-010-0840-z. Wien Med Wochenschr. 2010. PMID: 21170699 German.

5

Vascular cell adhesion molecule 1 in patients with severe osteoarthritis of the hip : A prospective cross-sectional study.

Oppl B, Datz C, Huber-Schönauer U, Husar-Memmer E, Brozek W, Zenz P, Gollob E, Wurnig C, Engel A, Klaushofer K, Zwerina J, Bartko J. Oppl B, et al. Among authors: klaushofer k. Wien Klin Wochenschr. 2019 Aug;131(15-16):369-373. doi: 10.1007/s00508-019-1497-2. Epub 2019 Apr 29. Wien Klin Wochenschr. 2019. PMID: 31037360 Free PMC article.

6

[Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].

Dimai HP, Pietschmann P, Resch H, Preisinger E, Fahrleitner-Pammer A, Dobnig H, Klaushofer K; Austrian Society for Bone and Mineral Research (AuSBMR). Dimai HP, et al. Among authors: klaushofer k. Wien Med Wochenschr Suppl. 2009;(122):1-34. doi: 10.1007/s10354-009-0656-x. Wien Med Wochenschr Suppl. 2009. PMID: 19484202 German.

7

Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.

Brozek W, Reichardt B, Zwerina J, Dimai HP, Klaushofer K, Zwettler E. Brozek W, et al. Among authors: klaushofer k. Osteoporos Int. 2016 Jan;27(1):387-96. doi: 10.1007/s00198-015-3415-4. Epub 2015 Nov 17. Osteoporos Int. 2016. PMID: 26576544

8

[Osteoporosis and metabolic bone diseases; clinical relationship].

Klaushofer K, Roschger P, Nader A, Glantschnig H, Varga F. Klaushofer K, et al. Wien Med Wochenschr. 1999;149(16-17):463-71. Wien Med Wochenschr. 1999. PMID: 10627983 Review. German.

9

Treatment Effects of Bisphosphonates and Denosumab on Survival and Refracture from Real-World Data of Hip-Fractured Patients.

Behanova M, Reichardt B, Stamm TA, Zwerina J, Klaushofer K, Kocijan R. Behanova M, et al. Among authors: klaushofer k. Calcif Tissue Int. 2019 Dec;105(6):630-641. doi: 10.1007/s00223-019-00611-3. Epub 2019 Sep 17. Calcif Tissue Int. 2019. PMID: 31531720

10

Inflammatory Bowel Disease: A Nationwide Study of Hip Fracture and Mortality Risk After Hip Fracture.

Bartko J, Reichardt B, Kocijan R, Klaushofer K, Zwerina J, Behanova M. Bartko J, et al. Among authors: klaushofer k. J Crohns Colitis. 2020 Sep 16;14(9):1256-1263. doi: 10.1093/ecco-jcc/jjaa052. J Crohns Colitis. 2020. PMID: 32170313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

361 results

Search Page